PL3429998T5 - Sposób wytwarzania pochodnych chinolin-2-ylo-fenyloaminy oraz jej soli - Google Patents
Sposób wytwarzania pochodnych chinolin-2-ylo-fenyloaminy oraz jej soliInfo
- Publication number
- PL3429998T5 PL3429998T5 PL17710769.5T PL17710769T PL3429998T5 PL 3429998 T5 PL3429998 T5 PL 3429998T5 PL 17710769 T PL17710769 T PL 17710769T PL 3429998 T5 PL3429998 T5 PL 3429998T5
- Authority
- PL
- Poland
- Prior art keywords
- salts
- phenylamine derivatives
- quinolin
- preparing
- preparing quinolin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16000662 | 2016-03-18 | ||
| EP16000661 | 2016-03-18 | ||
| EP17710769.5A EP3429998B3 (en) | 2016-03-18 | 2017-03-20 | Process for preparing quinolin-2-yl-phenylamine derivatives and their salts |
| PCT/EP2017/056544 WO2017158201A1 (en) | 2016-03-18 | 2017-03-20 | Process for preparing quinolin-2-yl-phenylamine derivatives and their salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL3429998T3 PL3429998T3 (pl) | 2022-03-14 |
| PL3429998T5 true PL3429998T5 (pl) | 2026-06-01 |
Family
ID=58277293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17710769.5T PL3429998T5 (pl) | 2016-03-18 | 2017-03-20 | Sposób wytwarzania pochodnych chinolin-2-ylo-fenyloaminy oraz jej soli |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10464903B2 (pl) |
| EP (1) | EP3429998B3 (pl) |
| DK (1) | DK3429998T6 (pl) |
| ES (1) | ES2899926T7 (pl) |
| FI (1) | FI3429998T6 (pl) |
| HR (1) | HRP20211779T4 (pl) |
| PL (1) | PL3429998T5 (pl) |
| PT (1) | PT3429998T (pl) |
| WO (1) | WO2017158201A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2757161A1 (en) | 2013-01-17 | 2014-07-23 | Splicos | miRNA-124 as a biomarker of viral infection |
| EP2974729A1 (en) | 2014-07-17 | 2016-01-20 | Abivax | Quinoline derivatives for use in the treatment of inflammatory diseases |
| WO2017158201A1 (en) | 2016-03-18 | 2017-09-21 | Ratiopharm Gmbh | Process for preparing quinolin-2-yl-phenylamine derivatives and their salts |
| EP3594205A1 (en) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-aryl derivatives for treating a rna virus infection |
| EP3594206A1 (en) | 2018-07-09 | 2020-01-15 | Abivax | Phenyl-n-quinoline derivatives for treating a rna virus infection |
| EP3669874A1 (en) * | 2018-12-20 | 2020-06-24 | Abivax | Quinoline derivatives for use in the treatment or prevention of cancer |
| EP3669873A1 (en) | 2018-12-20 | 2020-06-24 | Abivax | Quinoline derivatives for use ine the traeatment of inflammation diseases |
| EP3999493B1 (en) | 2019-07-19 | 2023-12-20 | Abivax | Aryl-n-aryl derivatives for treating a rna virus infection |
| KR102399037B1 (ko) * | 2020-01-06 | 2022-05-17 | 성균관대학교산학협력단 | 아민화된 아진의 신규한 제조방법 |
| EP3858815A1 (en) * | 2020-01-31 | 2021-08-04 | Abivax | Co-crystals and salts of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine |
| EP4063351A1 (en) | 2021-03-26 | 2022-09-28 | Abivax | Preparation method of quinoline derivative compounds |
| WO2022247920A1 (zh) | 2021-05-27 | 2022-12-01 | 江苏恒瑞医药股份有限公司 | 喹啉胺类化合物、其制备方法及其在医药上的应用 |
| TW202333698A (zh) * | 2022-01-24 | 2023-09-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 喹啉胺類化合物、其製備方法及其在醫藥上的應用 |
| TW202436296A (zh) | 2022-11-25 | 2024-09-16 | 大陸商江蘇恒瑞醫藥股份有限公司 | 喹啉胺類化合物晶型及其製備方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102625804B (zh) * | 2009-06-12 | 2015-04-08 | Abivax公司 | 用于治疗aids的化合物 |
| EP2465502A1 (en) * | 2010-12-15 | 2012-06-20 | Société Splicos | Compounds useful for treating AIDS |
| WO2017158201A1 (en) | 2016-03-18 | 2017-09-21 | Ratiopharm Gmbh | Process for preparing quinolin-2-yl-phenylamine derivatives and their salts |
-
2017
- 2017-03-20 WO PCT/EP2017/056544 patent/WO2017158201A1/en not_active Ceased
- 2017-03-20 DK DK17710769.5T patent/DK3429998T6/da active
- 2017-03-20 FI FIEP17710769.5T patent/FI3429998T6/fi active
- 2017-03-20 ES ES17710769T patent/ES2899926T7/es active Active
- 2017-03-20 PL PL17710769.5T patent/PL3429998T5/pl unknown
- 2017-03-20 HR HRP20211779TT patent/HRP20211779T4/hr unknown
- 2017-03-20 PT PT177107695T patent/PT3429998T/pt unknown
- 2017-03-20 US US16/084,891 patent/US10464903B2/en active Active
- 2017-03-20 EP EP17710769.5A patent/EP3429998B3/en active Active
-
2019
- 2019-11-01 US US16/671,278 patent/US10745357B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK3429998T6 (da) | 2026-05-11 |
| US20190077760A1 (en) | 2019-03-14 |
| US20200062713A1 (en) | 2020-02-27 |
| WO2017158201A1 (en) | 2017-09-21 |
| HRP20211779T1 (hr) | 2022-03-04 |
| ES2899926T7 (en) | 2026-05-20 |
| US10745357B2 (en) | 2020-08-18 |
| EP3429998A1 (en) | 2019-01-23 |
| PT3429998T (pt) | 2021-11-04 |
| PL3429998T3 (pl) | 2022-03-14 |
| US10464903B2 (en) | 2019-11-05 |
| DK3429998T3 (da) | 2021-11-22 |
| FI3429998T6 (fi) | 2026-05-19 |
| ES2899926T3 (es) | 2022-03-15 |
| EP3429998B1 (en) | 2021-09-01 |
| EP3429998B3 (en) | 2026-02-11 |
| HRP20211779T4 (hr) | 2026-04-24 |